Zacks Investment ResearchOct 27, 11:56 AM ET▲ Positive
Strong Earnings ESP of +26.45%, Zacks Rank #3 (Hold), and projected 62.9% YoY bottom-line improvement indicate significant earnings growth potential.
Korsana Biosciences news
$31.66+5.04%
Close Nov 2, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive1100% of coverage
Neutral00%
Negative00% of coverage
About Korsana Biosciences
No recent articles focused on Korsana Biosciences.
Also mentions KRSA
Articles that tag KRSA but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology